Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey

We compared severe acute respiratory syndrome–related coronavirus-2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April-May 2020 and found these two estimates to be similar (4.94% versus 3.18%). Compared with more re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Bajema, Kristina L, Dahlgren, F Scott, Lim, Travis W, Bestul, Nicolette, Biggs, Holly M, Tate, Jacqueline E, Owusu, Claudio, Szablewski, Christine M, Drenzek, Cherie, Drobeniuc, Jan, Semenova, Vera, Li, Han, Browning, Peter, Desai, Rita, Epperson, Monica, Jia, Lily T, Thornburg, Natalie J, Edens, Chris, Fry, Alicia M, Hall, Aron J, Schiffer, Jarad, Havers, Fiona P
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7799302/
https://ncbi.nlm.nih.gov/pubmed/33300579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1804
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars